Literature DB >> 3470317

Granular acute lymphoblastic leukaemia of childhood: a morphological phenomenon.

P J Darbyshire, J S Lilleyman.   

Abstract

Three hundred and twenty consecutive children with lymphoblastic leukaemia (ALL), treated on the Medical Research Council UKALL VIII schedule, had their Romanowsky stained diagnostic marrows reviewed for the presence of azurophil granules in blast cell cytoplasm. Twenty patients (7%) had greater than 5% blasts showing this feature; 19 had the cell phenotype of "common ALL." Male children and those with French-American-British (FAB) L2 morphology predominantly showed this feature. There was also a strong correlation between granularity and non-diffuse acid phosphate positivity, but no obvious difference between the 20 patients in their response to treatment emerged during a minimum follow up of 15 months. The "granular" variant occurs in around 7% of children with ALL, but has no clear prognostic importance. Morphologists should be aware of its existence and incidence to avoid confusion with acute myeloid leukaemia.

Entities:  

Mesh:

Year:  1987        PMID: 3470317      PMCID: PMC1140893          DOI: 10.1136/jcp.40.3.251

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

Review 1.  Definition of the cell types within the "null lymphocyte" population of human peripheral blood: an analysis of phenotypes and functions.

Authors:  M Ferrarini; C E Grossi
Journal:  Semin Hematol       Date:  1984-10       Impact factor: 3.851

2.  Childhood lymphoblastic leukemia with natural killer activity: establishment of the leukemia cell lines retaining the activity.

Authors:  A Komiyama; H Kawai; Y Miyagawa; T Akabane
Journal:  Blood       Date:  1982-12       Impact factor: 22.113

3.  Prognostic significance of vacuoles in L1 lymphoblasts in childhood acute lymphoblastic leukaemia: a report from Children's Cancer Study Group.

Authors:  V P Potter; M Sorell; J A Baglivo; H Sather; D R Miller
Journal:  Br J Haematol       Date:  1984-02       Impact factor: 6.998

4.  Sex and acid phosphatase in childhood non-T lymphoblastic leukaemia.

Authors:  J S Lilleyman; J A Britton; B J Laycock; P J Sugden
Journal:  J Clin Pathol       Date:  1980-02       Impact factor: 3.411

5.  Acute lymphoblastic leukemia--hand mirror cell variant: a detailed cytological and ultrastructural study with an analysis of the immunologic surface markers.

Authors:  S A Stass; E Perlin; E S Jaffe; D R Simon; W J Creegan; J J Robinson; M L Holloway; H R Schumacher
Journal:  Am J Hematol       Date:  1978       Impact factor: 10.047

6.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

7.  Prognostic importance of morphology (FAB classification) in childhood acute lymphoblastic leukaemia (ALL).

Authors:  D R Miller; S Leikin; V Albo; H Sather; D Hammond
Journal:  Br J Haematol       Date:  1981-06       Impact factor: 6.998

8.  Acute lymphoblastic leukemia with giant intracytoplasmic inclusions.

Authors:  E T Yanagihara; F Naeim; R P Gale; G Austin; J Waisman
Journal:  Am J Clin Pathol       Date:  1980-09       Impact factor: 2.493

9.  Acute lymphocytic leukemia with prominent azurophilic granulation and punctate acidic nonspecific esterase and phosphatase activity.

Authors:  T M Grogan; S J Insalaco; R A Savage; M L Vail
Journal:  Am J Clin Pathol       Date:  1981-05       Impact factor: 2.493

  9 in total
  2 in total

1.  Granular acute lymphoblastic leukemia in a 15-year-old boy.

Authors:  J Cap; O Babusikova; E Kaiserova; R Panzer-Grünmayer
Journal:  Med Oncol       Date:  2000-05       Impact factor: 3.064

Review 2.  Hypergranular acute lymphoblastic leukemia (ALL). Report of a case and review of the literature.

Authors:  I Schwarzinger; M Födinger; R Scherrer; M Wolzt; C Mannhalter; W Speiser
Journal:  Ann Hematol       Date:  1993-12       Impact factor: 3.673

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.